Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
11 Results for "
Rituximab
" in MedChemExpress (MCE) Product Catalog:
Products (11)
11 Results for "Rituximab" in MCE Product Catalog:
14
14 Publications Verification
Cat. No.: HY-P9913
CAS No.: 174722-31-7
Synonyms: Anti-Human CD20 type I, Chimeric Antibody; HSDB 7455; IDEC-C2B8
Research Areas:
14
14 Publications Verification
Cat. No.: HY-P9913A
CAS No.: 174722-31-7
Target:
Research Areas:
Cardiovascular Disease Neurological Disease Inflammation/Immunology Cancer
1
1 Cited Publications
Cat. No.: HY-P99055
CAS No.: 934823-49-1
Target:
Research Areas:
1
Target:
Research Areas:
Cat. No.: HY-P99759
CAS No.: 1622189-43-8
Synonyms: IL-15N72D
Target:
Research Areas:
Cat. No.: HY-P991225
Target:
Research Areas:
Cat. No.: HY-170899
CAS No.: 1801518-98-8
Target:
Research Areas:
TLR7 agonist 28 (compound 3) is a potent TLR7 agonist. TLR7 agonist 28 can conjugat to antitumor monoclonal antibodies (mAbs) for cancer immunotherapy .
Cat. No.: HY-P990649
CAS No.: 1169717-01-4
Synonyms: TRU-015
Target:
Research Areas:
Cat. No.: HY-P991902
Cat. No.: HY-178712
CAS No.: 521064-34-6
CT 32228 is an inhibitor of lysophosphatidic acid acyltransferase-β (LPAAT-β). CT 32228 inhibits tumor cell growth. CT 32228 exhibits IC50 values of around 0.1-0.8 μM in various leukemia cell lines. CT 32228 induces caspase activation in DHL-4 and Ramos cells. CT 32228 induces apoptosis when combined with Rituximab (HY-P9913). CT 32228 results in a 50% xenograft growth delay in vivo. CT 32228 can be studied in research on acute leukemia .
Cat. No.: HY-W1129940
CAS No.: 2417821-30-6
Research Areas:
p-SCN-Macropa is a bifunctional macrocyclic chelator featuring macrocyclic polyamine skeletons and thiocyanate (-SCN) reactive moieties. p-SCN-Macropa can conjugate with monoclonal antibodies including Nimotuzumab (HY-P9968), Rituximab (HY-P9913) and Trastuzumab (HY-P9907)-PEG6-DM1 for 225Ac radiolabeling to construct radioimmunoconjugates. p-SCN-Macropa is applicable for the research of colorectal cancer, HER2-positive breast cancer, TROP-2-positive cancers, and PSMA-positive cancers .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
